Age, Biography and Wiki
Kim Jin-soo was born on 29 May, 1964 in Korean, is a Korean scientist. Discover Kim Jin-soo's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 60 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
60 years old |
Zodiac Sign |
Gemini |
Born |
29 May 1964 |
Birthday |
29 May |
Birthplace |
N/A |
Nationality |
Korean |
We recommend you to check the complete list of Famous People born on 29 May.
He is a member of famous with the age 60 years old group.
Kim Jin-soo Height, Weight & Measurements
At 60 years old, Kim Jin-soo height not available right now. We will update Kim Jin-soo's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Family |
Parents |
Not Available |
Wife |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Kim Jin-soo Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Kim Jin-soo worth at the age of 60 years old? Kim Jin-soo’s income source is mostly from being a successful . He is from Korean. We have estimated
Kim Jin-soo's net worth
, money, salary, income, and assets.
Net Worth in 2023 |
$1 Million - $5 Million |
Salary in 2023 |
Under Review |
Net Worth in 2022 |
Pending |
Salary in 2022 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Kim Jin-soo Social Network
Timeline
Kim Jin-soo is a chemist, biologist, and entrepreneur. He was CEO and CSO, ToolGen, Inc., is a professor in the Department of Chemistry of Seoul National University and director of the Center for Genome Engineering. His research team has developed and improved several types of programmable nucleases, specifically zinc finger nucleases (ZFNs), TAL effector nucleases (TALENs), and RNA-guided engineered nucleases (RGENs). In 2018, he was a Clarivate Analytics Highly Cited Researcher in the cross-field category and in the biology and biochemistry category in 2019.
CRISPR-Cas9 is a widely used genetic tool but lacked methods to test its accuracy genome-wide. In 2015, Kim's IBS Center, Seoul National University, and ToolGen jointly published a paper in Nature Methods outlining their technique named Digenome-seq which locates on-target and off-target sequences in CRISPR-Cas9. He has continued to research increasing the accuracy of the process.
He first worked as a research associate at the Howard Hughes Medical Institute and Massachusetts Institute of Technology for a period of just under three years. In 1997, he became a principal investigator at the Samsung Biomedical Research Institute. In 1999, he left that position to be the CEO and CSO of ToolGen; a company he founded. ToolGen is a biotech company based on CRISPR technology focusing on human therapies, and molecular breeding in plants and animals. In 2005, the company was among the Top 10 Biotech Companies to Watch in Asia at the Pacific Rim Forum/China Council for the Promotion of Industrial Trade. In that same year, he left his CEO position and started working at Seoul National University as an assistant professor, then associate and then full professor. From 2014, he became the founding director of the Center for Genome Engineering under the Institute for Basic Science (IBS).
Kim studied chemistry at Seoul National University from 1983 and received a B.S. in 1987 and M.S. in 1989. Changing majors to biochemistry, he received a Ph.D. from University of Wisconsin-Madison in 1994. During the final two years of his doctorate program, he was the recipient of the Steenbock Predoctoral Fellowship.